Mylan acquires Merck generic pharmaceutical company for $7B

TriMed Staff | | Health Imaging | Diagnostic Imaging
Mylan has completed the acquisition of Merck KGaA's generics business for $6.95 billion in an all-cash transaction.

With the acquisition, the Pittsburgh-based Mylan said it will employ more than 11,000 staff, and its product offering will now include more than 570 products.

Mylan also announced that the company will change its name from Mylan Laboratories Inc. to Mylan Inc, and it has changed its financial year to begin reporting on a calendar- year basis.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.